Beyond the Prevention of Anti-drug Antibody Formation with Uricase Therapy: Mechanistic Roles of DMARDs in Modifying Gout Flare Risk

Ted R. Mikuls, Tuhina Neogi, Angelo Gaffo

Open source

DOI
10.1007/s40259-026-00808-7
Published
2026-09-14
Container
BioDrugs
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s40259-026-00808-7,
  title = {Beyond the Prevention of Anti-drug Antibody Formation with Uricase Therapy: Mechanistic Roles of DMARDs in Modifying Gout Flare Risk},
  author = {Ted R. Mikuls and Tuhina Neogi and Angelo Gaffo},
  year = {2026},
  journal = {BioDrugs},
  doi = {10.1007/s40259-026-00808-7},
  url = {https://doi.org/10.1007/s40259-026-00808-7}
}

RIS

TY  - JOUR
TI  - Beyond the Prevention of Anti-drug Antibody Formation with Uricase Therapy: Mechanistic Roles of DMARDs in Modifying Gout Flare Risk
AU  - Ted R. Mikuls
AU  - Tuhina Neogi
AU  - Angelo Gaffo
PY  - 2026
JO  - BioDrugs
DO  - 10.1007/s40259-026-00808-7
UR  - https://doi.org/10.1007/s40259-026-00808-7
ER  - 

APA

Mikuls, T. R., Neogi, T., & Gaffo, A. (2026). Beyond the Prevention of Anti-drug Antibody Formation with Uricase Therapy: Mechanistic Roles of DMARDs in Modifying Gout Flare Risk. BioDrugs. https://doi.org/10.1007/s40259-026-00808-7

Source records